"Structure Activity Models - Optimizing the drug´s structure"

 
     
 

[Q]SAR of substances in view of nuclear receptors (focusing on PPAR)

[Q]SAR of drugs in view of the target and possible side effects (focussing on drugs affecting the CNS)


Application of machine learning approaches for the derivation of structure-activity-relationships